MedPath

Hydrocortisone

TOPICAL CORTICOSTEROID

Approved
Approval ID

aa9dba84-eb38-4ec3-8555-87c948bf2384

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 10, 2020

Manufacturers
FDA

Actavis Pharma, Inc.

DUNS: 119723554

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrocortisone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0472-0321
Application NumberANDA087795
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydrocortisone
Product Specifications
Route of AdministrationTOPICAL
Effective DateJune 30, 2017
FDA Product Classification

INGREDIENTS (10)

SORBITAN MONOSTEARATEInactive
Code: NVZ4I0H58X
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HYDROCORTISONEActive
Quantity: 10 mg in 1 g
Code: WI4X0X7BPJ
Classification: ACTIB
STEARYL ALCOHOLInactive
Code: 2KR89I4H1Y
Classification: IACT
PARAFFINInactive
Code: I9O0E3H2ZE
Classification: IACT
LACTIC ACIDInactive
Code: 33X04XA5AT
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
GLYCERYL MONOSTEARATEInactive
Code: 230OU9XXE4
Classification: IACT
POLYOXYL 40 STEARATEInactive
Code: 13A4J4NH9I
Classification: IACT
ISOPROPYL PALMITATEInactive
Code: 8CRQ2TH63M
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydrocortisone - FDA Drug Approval Details